Global NK Cell Therapy Market Insights And Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global NK Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NK Cell Therapy Market Perspective (2017-2028)
2.2 NK Cell Therapy Growth Trends by Region
2.2.1 NK Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NK Cell Therapy Historic Market Size by Region (2017-2022)
2.2.3 NK Cell Therapy Forecasted Market Size by Region (2023-2028)
2.3 NK Cell Therapy Market Dynamics
2.3.1 NK Cell Therapy Industry Trends
2.3.2 NK Cell Therapy Market Drivers
2.3.3 NK Cell Therapy Market Challenges
2.3.4 NK Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NK Cell Therapy Players by Revenue
3.1.1 Global Top NK Cell Therapy Players by Revenue (2017-2022)
3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2017-2022)
3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NK Cell Therapy Revenue
3.4 Global NK Cell Therapy Market Concentration Ratio
3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2021
3.5 NK Cell Therapy Key Players Head office and Area Served
3.6 Key Players NK Cell Therapy Product Solution and Service
3.7 Date of Enter into NK Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NK Cell Therapy Breakdown Data by Type
4.1 Global NK Cell Therapy Historic Market Size by Type (2017-2022)
4.2 Global NK Cell Therapy Forecasted Market Size by Type (2023-2028)
5 NK Cell Therapy Breakdown Data by Application
5.1 Global NK Cell Therapy Historic Market Size by Application (2017-2022)
5.2 Global NK Cell Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NK Cell Therapy Market Size (2017-2028)
6.2 North America NK Cell Therapy Market Size by Type
6.2.1 North America NK Cell Therapy Market Size by Type (2017-2022)
6.2.2 North America NK Cell Therapy Market Size by Type (2023-2028)
6.2.3 North America NK Cell Therapy Market Share by Type (2017-2028)
6.3 North America NK Cell Therapy Market Size by Application
6.3.1 North America NK Cell Therapy Market Size by Application (2017-2022)
6.3.2 North America NK Cell Therapy Market Size by Application (2023-2028)
6.3.3 North America NK Cell Therapy Market Share by Application (2017-2028)
6.4 North America NK Cell Therapy Market Size by Country
6.4.1 North America NK Cell Therapy Market Size by Country (2017-2022)
6.4.2 North America NK Cell Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe NK Cell Therapy Market Size (2017-2028)
7.2 Europe NK Cell Therapy Market Size by Type
7.2.1 Europe NK Cell Therapy Market Size by Type (2017-2022)
7.2.2 Europe NK Cell Therapy Market Size by Type (2023-2028)
7.2.3 Europe NK Cell Therapy Market Share by Type (2017-2028)
7.3 Europe NK Cell Therapy Market Size by Application
7.3.1 Europe NK Cell Therapy Market Size by Application (2017-2022)
7.3.2 Europe NK Cell Therapy Market Size by Application (2023-2028)
7.3.3 Europe NK Cell Therapy Market Share by Application (2017-2028)
7.4 Europe NK Cell Therapy Market Size by Country
7.4.1 Europe NK Cell Therapy Market Size by Country (2017-2022)
7.4.2 Europe NK Cell Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NK Cell Therapy Market Size (2017-2028)
8.2 Asia-Pacific NK Cell Therapy Market Size by Type
8.2.1 Asia-Pacific NK Cell Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NK Cell Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NK Cell Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific NK Cell Therapy Market Size by Application
8.3.1 Asia-Pacific NK Cell Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NK Cell Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NK Cell Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific NK Cell Therapy Market Size by Region
8.4.1 Asia-Pacific NK Cell Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NK Cell Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NK Cell Therapy Market Size (2017-2028)
9.2 Latin America NK Cell Therapy Market Size by Type
9.2.1 Latin America NK Cell Therapy Market Size by Type (2017-2022)
9.2.2 Latin America NK Cell Therapy Market Size by Type (2023-2028)
9.2.3 Latin America NK Cell Therapy Market Share by Type (2017-2028)
9.3 Latin America NK Cell Therapy Market Size by Application
9.3.1 Latin America NK Cell Therapy Market Size by Application (2017-2022)
9.3.2 Latin America NK Cell Therapy Market Size by Application (2023-2028)
9.3.3 Latin America NK Cell Therapy Market Share by Application (2017-2028)
9.4 Latin America NK Cell Therapy Market Size by Country
9.4.1 Latin America NK Cell Therapy Market Size by Country (2017-2022)
9.4.2 Latin America NK Cell Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NK Cell Therapy Market Size (2017-2028)
10.2 Middle East & Africa NK Cell Therapy Market Size by Type
10.2.1 Middle East & Africa NK Cell Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NK Cell Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NK Cell Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa NK Cell Therapy Market Size by Application
10.3.1 Middle East & Africa NK Cell Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NK Cell Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NK Cell Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa NK Cell Therapy Market Size by Country
10.4.1 Middle East & Africa NK Cell Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NK Cell Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Company Details
11.1.2 Nektar Therapeutics Business Overview
11.1.3 Nektar Therapeutics NK Cell Therapy Introduction
11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
11.1.5 Nektar Therapeutics Recent Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Company Details
11.2.2 Innate Pharma SA Business Overview
11.2.3 Innate Pharma SA NK Cell Therapy Introduction
11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022)
11.2.5 Innate Pharma SA Recent Developments
11.3 Affimed
11.3.1 Affimed Company Details
11.3.2 Affimed Business Overview
11.3.3 Affimed NK Cell Therapy Introduction
11.3.4 Affimed Revenue in NK Cell Therapy Business (2017-2022)
11.3.5 Affimed Recent Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Company Details
11.4.2 Chipscreen Biosciences Business Overview
11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction
11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022)
11.4.5 Chipscreen Biosciences Recent Developments
11.5 Fate Therapeutics
11.5.1 Fate Therapeutics Company Details
11.5.2 Fate Therapeutics Business Overview
11.5.3 Fate Therapeutics NK Cell Therapy Introduction
11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
11.5.5 Fate Therapeutics Recent Developments
11.6 Glycostem Therapeutics
11.6.1 Glycostem Therapeutics Company Details
11.6.2 Glycostem Therapeutics Business Overview
11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction
11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
11.6.5 Glycostem Therapeutics Recent Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Company Details
11.7.2 Dragonfly Therapeutics Business Overview
11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction
11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
11.7.5 Dragonfly Therapeutics Recent Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Company Details
11.8.2 Kiadis Pharma Business Overview
11.8.3 Kiadis Pharma NK Cell Therapy Introduction
11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022)
11.8.5 Kiadis Pharma Recent Developments
11.9 NantWorks
11.9.1 NantWorks Company Details
11.9.2 NantWorks Business Overview
11.9.3 NantWorks NK Cell Therapy Introduction
11.9.4 NantWorks Revenue in NK Cell Therapy Business (2017-2022)
11.9.5 NantWorks Recent Developments
11.10 Nkarta Therapeutics
11.10.1 Nkarta Therapeutics Company Details
11.10.2 Nkarta Therapeutics Business Overview
11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction
11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022)
11.10.5 Nkarta Therapeutics Recent Developments
11.11 Fortress Biotech
11.11.1 Fortress Biotech Company Details
11.11.2 Fortress Biotech Business Overview
11.11.3 Fortress Biotech NK Cell Therapy Introduction
11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022)
11.11.5 Fortress Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global NK Cell Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global NK Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global NK Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global NK Cell Therapy Market Share by Region (2017-2022)
Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global NK Cell Therapy Market Share by Region (2023-2028)
Table 10. NK Cell Therapy Market Trends
Table 11. NK Cell Therapy Market Drivers
Table 12. NK Cell Therapy Market Challenges
Table 13. NK Cell Therapy Market Restraints
Table 14. Global NK Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global NK Cell Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top NK Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2021)
Table 17. Ranking of Global Top NK Cell Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NK Cell Therapy Product Solution and Service
Table 21. Date of Enter into NK Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global NK Cell Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global NK Cell Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global NK Cell Therapy Revenue Share by Application (2017-2022)
Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global NK Cell Therapy Revenue Share by Application (2023-2028)
Table 31. North America NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific NK Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific NK Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa NK Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa NK Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa NK Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa NK Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa NK Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa NK Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Nektar Therapeutics Company Details
Table 62. Nektar Therapeutics Business Overview
Table 63. Nektar Therapeutics NK Cell Therapy Product
Table 64. Nektar Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 65. Nektar Therapeutics Recent Developments
Table 66. Innate Pharma SA Company Details
Table 67. Innate Pharma SA Business Overview
Table 68. Innate Pharma SA NK Cell Therapy Product
Table 69. Innate Pharma SA Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 70. Innate Pharma SA Recent Developments
Table 71. Affimed Company Details
Table 72. Affimed Business Overview
Table 73. Affimed NK Cell Therapy Product
Table 74. Affimed Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 75. Affimed Recent Developments
Table 76. Chipscreen Biosciences Company Details
Table 77. Chipscreen Biosciences Business Overview
Table 78. Chipscreen Biosciences NK Cell Therapy Product
Table 79. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 80. Chipscreen Biosciences Recent Developments
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics NK Cell Therapy Product
Table 84. Fate Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 85. Fate Therapeutics Recent Developments
Table 86. Glycostem Therapeutics Company Details
Table 87. Glycostem Therapeutics Business Overview
Table 88. Glycostem Therapeutics NK Cell Therapy Product
Table 89. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 90. Glycostem Therapeutics Recent Developments
Table 91. Dragonfly Therapeutics Company Details
Table 92. Dragonfly Therapeutics Business Overview
Table 93. Dragonfly Therapeutics NK Cell Therapy Product
Table 94. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 95. Dragonfly Therapeutics Recent Developments
Table 96. Kiadis Pharma Company Details
Table 97. Kiadis Pharma Business Overview
Table 98. Kiadis Pharma NK Cell Therapy Product
Table 99. Kiadis Pharma Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 100. Kiadis Pharma Recent Developments
Table 101. NantWorks Company Details
Table 102. NantWorks Business Overview
Table 103. NantWorks NK Cell Therapy Product
Table 104. NantWorks Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 105. NantWorks Recent Developments
Table 106. Nkarta Therapeutics Company Details
Table 107. Nkarta Therapeutics Business Overview
Table 108. Nkarta Therapeutics NK Cell Therapy Product
Table 109. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 110. Nkarta Therapeutics Recent Developments
Table 111. Fortress Biotech Company Details
Table 112. Fortress Biotech Business Overview
Table 113. Fortress Biotech NK Cell Therapy Product
Table 114. Fortress Biotech Revenue in NK Cell Therapy Business (2017-2022) & (US$ Million)
Table 115. Fortress Biotech Recent Developments
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NK Cell Therapy Market Share by Type: 2021 VS 2028
Figure 2. NK Cell Therapies Features
Figure 3. NK Cell Directed Antibodies Features
Figure 4. Global NK Cell Therapy Market Share by Application: 2021 VS 2028
Figure 5. Cancer Case Studies
Figure 6. Gastrointestinal Diseases Case Studies
Figure 7. Others Case Studies
Figure 8. NK Cell Therapy Report Years Considered
Figure 9. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global NK Cell Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global NK Cell Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global NK Cell Therapy Market Share by Players in 2021
Figure 13. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2021
Figure 15. North America NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America NK Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 17. North America NK Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 18. North America NK Cell Therapy Market Size Share by Country (2017-2028)
Figure 19. United States NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe NK Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 23. Europe NK Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 24. Europe NK Cell Therapy Market Size Share by Country (2017-2028)
Figure 25. Germany NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific NK Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific NK Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific NK Cell Therapy Market Size Share by Region (2017-2028)
Figure 35. China NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America NK Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 43. Latin America NK Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 44. Latin America NK Cell Therapy Market Size Share by Country (2017-2028)
Figure 45. Mexico NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa NK Cell Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa NK Cell Therapy Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa NK Cell Therapy Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa NK Cell Therapy Market Size Share by Country (2017-2028)
Figure 51. Turkey NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE NK Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 55. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 56. Affimed Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 57. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 58. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 59. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 60. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 61. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 62. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 63. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 64. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.